Healthcare -
Biotechnology - NASDAQ - US
$ 46.86
-4.01 %
$ 2.02 B
Market Cap
-10.7
P/E
SLNO - OPERATING INCOME
Operating Income SLNO - Soleno Therapeutics, Inc.
-41.4 M
LAST VALUE
-14.57%
2 YEAR CAGR
-23.68%
5 YEAR CAGR
-47.54%
10 YEAR CAGR